Retatrutide 10mg – lower-dose triple GIP/GLP-1/glucagon receptor triagonist (CAS 2381089-83-2, ~4,681 Da) for dose-range studies and preclinical metabolic research into coordinated incretin signalling. ≥98% purity.
Retatrutide 10mg – lower-dose triple GIP/GLP-1/glucagon receptor triagonist (CAS 2381089-83-2, ~4,681 Da) for dose-range studies and preclinical metabolic research into coordinated incretin signalling. ≥98% purity.
